Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors

NCT04794972

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Affiliated Cancer Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • ZhuJiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
View Trial Details
Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations
  • Helios Clinical Research Cerritos, California, United States
  • California Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 102 locations
View Trial Details
Recruiting

Mental Health and Suicidality in Glioblastoma Patients in Germany

NCT07409584

Conditions
Astrocytoma, Behavior, Behavioral Symptoms, +14 more
Locations
  • Charite Berlin, Germany
  • University Hospital Knappschaftskrankenhaus Bochum Bochum, Germany
  • University Hospital Essen Essen, Germany
  • University hospital Hamburg Eppendorf Hamburg, Germany
View Trial Details
Recruiting

MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.

NCT07607769

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research site Ancona, Italy
  • Research site Foggia, Italy
  • Research site Milan, Italy
  • Research site Modena, Italy
View all 16 locations
View Trial Details

Related conditions